By: Maribel Yoo On: February 10, 2017 In: Nexus Strategy, Portfolio Comments: 0

Sisu Global Health ( is a medical technology company focused on the rapidly expanding market of emerging economies.

Sisu creates devices that meet critical needs under the constraints of the low-resource communities in which they will be deployed. With five technologies in its portfolio, Sisu sets to prove its model with Hemafuse: a handheld device that enables clinicians to recycle blood from patients with internal bleeding, reducing the need for donor blood. This year Sisu began selling Hemafuse in Africa through Kenya’s largest med-pharma distributor. Sisu has won numerous awards including the First Mile Innovation Challenges from GE and Massachusetts General Hospital; and has been featured in CBS 60 Minutes, USA Today, Entrepreneur Magazine, and Business Insider.

Deal Source

Johns Hopkins Technology Ventures

Board Representation

George Petrocheilos